Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint

Molecular Cancer Therapeutics

Volumn 2, Issue 6, 2003, Pages 543-548

  Chen, Zehan ^a   Xiao, Zhan ^a   Chen, Jun ^a   Ng, Shi Chung ^a   Sowin, Thomas ^a   Sham, Hing ^a   Rosenberg, Saul ^a   Fesik, Steve ^a   Zhang, Haiying ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; PROTEIN KINASE; PROTEIN P53; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DEATH; DNA DAMAGE; HELA CELL; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; G2 PHASE; HELA CELLS; HUMANS; KINETICS; PROTEIN KINASES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542754615     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543-546, 1992.
2. Liu, Q., Guntuku, S., Cui, X. S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., Donehower, L. A., and Elledge, S. J. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev., 14: 1448-1459, 2000. (Pubitemid 30421838)
3. 2 delay. Cancer Res., 55: 1643-1648, 1995.
4. 2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene, 20: 7453-7463, 2001.
5. 2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst. (Bethesda), 88:956-965, 1996.
6. Jackson, J. R., Gilmartin, A., Imburgia, C., Winkler, J. D., Marshall, L. A., and Roshak, A. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res., 60: 566-572, 2000. (Pubitemid 30094552)
7. Kawakami, K., Futami, H., Takahara, J., and Yamaguchi, K. UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem. Biophys. Res. Commun., 219: 778-783, 1996.
8. Kohn, E. A., Ruth, N. D., Brown, M. K., Livingstone, M., and Eastman, A. Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of UCN-01 and the kinetics of Cdc25C activation. J. Biol. Chem., 277:26553-26564, 2002. (Pubitemid 34967153)
9. Monks, A., Harris, E. D., Vaigro-Wolff, A., Hose, C. D., Connelly, J. W., and Sausville, E. A. UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines. Invest. New Drugs, 18: 95-107, 2000. (Pubitemid 30261284)
10. Takai, H., Tominaga, K., Motoyama, N., Minamishima, Y. A., Nagahama, H., Tsukiyama, T., Ikeda, K., Nakayama, K., Nakanishi, M., and Nakayama, K. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev., 14: 1439-1447, 2000. (Pubitemid 30421837)
11. Chen, Z., Ko, A., Yang, J., and Jordan, V. C. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. Br. J. Cancer, 77: 181-185, 1998. (Pubitemid 28029532)
12. Liu, X., Shi, Y., Han, E. K., Chen, Z., Rosenberg, S. H., Giranda, V. L., Luo, Y., and Ng, S. C. Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells. Neoplasia, 3:278-286, 2001. (Pubitemid 32801878)
13. Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., Birch, J. M., Li, F. P., Garber, J. E., and Haber, D. A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (Wash. DC), 286: 2528-2531, 1999.
14. Luo, Y., Rockow-Magnone, S. K., Kroeger, P. E., Frost, L., Chen, Z., Han, E. K., Ng, S. C., Simmer, R. L., and Giranda, V. L. Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism. Neoplasia, 3: 411-419, 2001. (Pubitemid 32988811)
15. Suganuma, M., Kawabe, T., Hori, H., Funabiki, T., and Okamoto, T. Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res., 59: 5887-5891, 1999. (Pubitemid 30004945)
16. Zachos, G., Rainey, M. D., and Gillespie, D. A. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J., 22: 713-723, 2003. (Pubitemid 36193615)
17. 2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents. Anticancer Res., 21: 23-28, 2001.
18. 1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc. Natl. Acad. Sci. USA, 98: 9092-9097, 2001.